All Programs

Use the tool below to view all available Prova Series

Innovations in Ig Treatments in CIDP
Innovations in Ig Treatments in CIDP
CME/CE Live Broadcast
Innovations in Ig Treatments in CIDP
March 26, 2025
12:00 PM - 01:00 PM EDT
Learn more
Chairperson’s Perspective: Treating At-Risk MASH: What Are You Waiting For?
Chairperson’s Perspective: Treating At-Risk MASH: What Are You Waiting For?
CME/CE
Chairperson’s Perspective: Treating At-Risk MASH: What Are You Waiting For?
0.25 credits
- Mazen Noureddin, MD, MHSc
0.25 credits
What’s New in Glaucoma Topical Therapies?
What’s New in Glaucoma Topical Therapies?
MinuteCE®
What’s New in Glaucoma Topical Therapies?
1.00 program credit
- Justin Schweitzer, OD, FAAO
- Sarah H. Van Tassel, MD
1.00 program credit
New Solutions for Optimizing IOP Control: A Case-Based Approach
New Solutions for Optimizing IOP Control: A Case-Based Approach
MinuteCE®
New Solutions for Optimizing IOP Control: A Case-Based Approach
1.00 program credit
- Sarah H. Van Tassel, MD
- Justin Schweitzer, OD, FAAO
1.00 program credit
3D Heads-Up Visualization: Cases in Glaucoma Surgery
3D Heads-Up Visualization: Cases in Glaucoma Surgery
MinuteCE®
3D Heads-Up Visualization: Cases in Glaucoma Surgery
1.00 program credit
- Paul Petrakos, DO, MS
- I. Paul Singh, MD
1.00 program credit
Recent Updates on Ovarian Function Suppression in Premenopausal HR+ Early-Stage Breast Cancer
Recent Updates on Ovarian Function Suppression in Premenopausal HR+ Early-Stage Breast Cancer
MinuteCE®
Recent Updates on Ovarian Function Suppression in Premenopausal HR+ Early-Stage Breast Cancer
0.50 program credits
- Sandra Swain, MD
- Virginia Kaklamani, MD
0.50 program credits
MinuteCE®
Optimizing Ovarian Function Suppression in Hormone Receptor-Positive Breast Cancer: Best Practices for the Community Clinician
0.50 credits 4 episodes
- Sandra Swain, MD
- Virginia Kaklamani, MD
0.50 credits 4 episodes
Future Directions of Ovarian Function Suppression: Answering Unmet Needs in Premenopausal HR+ Early-Stage Breast Cancer
Future Directions of Ovarian Function Suppression: Answering Unmet Needs in Premenopausal HR+ Early-Stage Breast Cancer
MinuteCE®
Future Directions of Ovarian Function Suppression: Answering Unmet Needs in Premenopausal HR+ Early-Stage Breast Cancer
0.50 program credits
- Sandra Swain, MD
- Virginia Kaklamani, MD
0.50 program credits
Duration of Ovarian Function Suppression in Premenopausal HR+ Early-Stage Breast Cancer
Duration of Ovarian Function Suppression in Premenopausal HR+ Early-Stage Breast Cancer
MinuteCE®
Duration of Ovarian Function Suppression in Premenopausal HR+ Early-Stage Breast Cancer
0.50 program credits
- Sandra Swain, MD
- Virginia Kaklamani, MD
0.50 program credits
Innovative Approaches to IBS-C: Personalized Treatment for Better Outcomes
Innovative Approaches to IBS-C: Personalized Treatment for Better Outcomes
CME/CE Live Broadcast
Innovative Approaches to IBS-C: Personalized Treatment for Better Outcomes
May 04, 2025
09:30 PM - 10:30 PM ET
1.00 credit Learn more
Molecular Profiling for HER2+ Advanced Solid Tumors
Molecular Profiling for HER2+ Advanced Solid Tumors
CME/CE
Molecular Profiling for HER2+ Advanced Solid Tumors
1.00 credit
- Eric Van Cutsem, MD, PhD
- David SP Tan, MBBS, PhD, PRCP
- James Chih-Hsin Yang, MD, PhD
- Kathleen Moore, MD, MS, FASCO
1.00 credit
Maximizing Myeloma Outcomes With GPRC5D-Directed Therapy: Practical Expert Case Studies and Best Practices
Maximizing Myeloma Outcomes With GPRC5D-Directed Therapy: Practical Expert Case Studies and Best Practices
CME/CE
Maximizing Myeloma Outcomes With GPRC5D-Directed Therapy: Practical Expert Case Studies and Best Practices
0.25 credits
- Jeffrey V. Matous, MD
- Donna Catamero, NP
0.25 credits
Patient Partners in NSCLC: Collaborating to Enhance Quality of Life and Outcomes With EGFRi-Associated Dermatologic Toxicities
Patient Partners in NSCLC: Collaborating to Enhance Quality of Life and Outcomes With EGFRi-Associated Dermatologic Toxicities
CME/CE
Patient Partners in NSCLC: Collaborating to Enhance Quality of Life and Outcomes With EGFRi-Associated Dermatologic Toxicities
0.25 credits
- Jonathan Leventhal, MD
- Shahnaz Singh-Kandah, NP
0.25 credits
The Power of Shared Decision-Making in Obesity Care
The Power of Shared Decision-Making in Obesity Care
MinuteCE®
The Power of Shared Decision-Making in Obesity Care
1.50 program credits
- Charles P. Vega, MD
1.50 program credits
A Global Health Crisis
A Global Health Crisis
MinuteCE®
A Global Health Crisis
1.50 program credits
- Donna Ryan, MD
1.50 program credits
Pharmacotherapy in Obesity: Current and Emerging Options
Pharmacotherapy in Obesity: Current and Emerging Options
MinuteCE®
Pharmacotherapy in Obesity: Current and Emerging Options
1.50 program credits
- Donna Ryan, MD
- Andreea Ciudin, MD, PhD
1.50 program credits

All Programs

Popular

Title

Share on ReachMD